Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Issie Kirby is an analyst at Redburn Atlantic. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/09/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
02/03/2025 | DXCM | Buy Now | DexCom | $84.59 | 35.95% | Issie Kirby26% | $85 → $115 | Upgrade | Neutral → Buy | Get Alert |
10/10/2024 | ALC | Buy Now | Alcon | $96.68 | — | Issie Kirby26% | — | Upgrade | Sell → Neutral | Get Alert |
05/30/2024 | DXCM | Buy Now | DexCom | $84.59 | 53.68% | Issie Kirby26% | → $130 | Initiates | → Neutral | Get Alert |
05/30/2024 | TNDM | Buy Now | Tandem Diabetes Care | $22.76 | 163.62% | Issie Kirby26% | → $60 | Initiates | → Buy | Get Alert |
05/30/2024 | PODD | Buy Now | Insulet | $312.00 | -24.68% | Issie Kirby26% | → $235 | Initiates | → Buy | Get Alert |
03/19/2024 | COO | Buy Now | Cooper Companies | $82.27 | 51.94% | Issie Kirby26% | → $125 | Upgrade | Neutral → Buy | Get Alert |
10/05/2023 | COO | Buy Now | Cooper Companies | $82.27 | 316.92% | Issie Kirby26% | $390 → $343 | Downgrade | Buy → Neutral | Get Alert |